GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS)
CNY 12.78
(-0.47%)
CNY 12.78
(-0.47%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 292.7 Million CNY | 45.42% |
| 2022 | 201.28 Million CNY | 32.18% |
| 2021 | 152.28 Million CNY | 62.08% |
| 2020 | 93.95 Million CNY | -29.4% |
| 2019 | 133.08 Million CNY | 20.45% |
| 2018 | 110.48 Million CNY | 26.08% |
| 2017 | 87.62 Million CNY | 17.03% |
| 2016 | 74.87 Million CNY | 42.33% |
| 2015 | 52.61 Million CNY | 81.45% |
| 2014 | 28.99 Million CNY | 49.66% |
| 2013 | 19.37 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 77.07 Million CNY | 26.32% |
| 2024 Q1 | 56.04 Million CNY | -58.4% |
| 2024 Q2 | 61.01 Million CNY | 8.86% |
| 2023 Q3 | 57.01 Million CNY | 23.92% |
| 2023 Q4 | 134.73 Million CNY | 136.3% |
| 2023 FY | 292.7 Million CNY | 45.42% |
| 2023 Q1 | 54.93 Million CNY | -43.74% |
| 2023 Q2 | 46.01 Million CNY | -16.24% |
| 2022 Q2 | 40.26 Million CNY | 69.67% |
| 2022 Q1 | 23.72 Million CNY | -41.2% |
| 2022 FY | 201.28 Million CNY | 32.18% |
| 2022 Q4 | 97.64 Million CNY | 146.28% |
| 2022 Q3 | 39.64 Million CNY | -1.53% |
| 2021 Q4 | 40.35 Million CNY | -5.12% |
| 2021 FY | 152.28 Million CNY | 62.08% |
| 2021 Q2 | 45.94 Million CNY | 96.01% |
| 2021 Q1 | 23.44 Million CNY | -48.26% |
| 2021 Q3 | 42.53 Million CNY | -7.43% |
| 2020 Q4 | 45.3 Million CNY | 1986.5% |
| 2020 FY | 93.95 Million CNY | -29.4% |
| 2020 Q2 | 20.6 Million CNY | -20.37% |
| 2020 Q1 | 25.87 Million CNY | -33.68% |
| 2020 Q3 | 2.17 Million CNY | -89.46% |
| 2019 Q1 | 21.78 Million CNY | 0.0% |
| 2019 FY | 133.08 Million CNY | 20.45% |
| 2019 Q4 | 39.01 Million CNY | 0.08% |
| 2019 Q3 | 38.98 Million CNY | 17.1% |
| 2019 Q2 | 33.29 Million CNY | 52.81% |
| 2018 FY | 110.48 Million CNY | 26.08% |
| 2018 Q2 | 29.15 Million CNY | 4.1% |
| 2018 Q1 | 28 Million CNY | -10.7% |
| 2017 FY | 87.62 Million CNY | 17.03% |
| 2017 Q1 | 10.05 Million CNY | -50.74% |
| 2017 Q3 | 31.36 Million CNY | 0.0% |
| 2017 Q4 | 31.36 Million CNY | 0.0% |
| 2016 Q4 | 20.41 Million CNY | 0.0% |
| 2016 Q1 | 17.02 Million CNY | 18.7% |
| 2016 Q2 | 17.02 Million CNY | 0.0% |
| 2016 Q3 | 20.41 Million CNY | 19.88% |
| 2016 FY | 74.87 Million CNY | 42.33% |
| 2015 Q3 | 14.34 Million CNY | 19.94% |
| 2015 Q1 | 11.96 Million CNY | 48.86% |
| 2015 Q4 | 14.34 Million CNY | 0.0% |
| 2015 Q2 | 11.96 Million CNY | -0.0% |
| 2015 FY | 52.61 Million CNY | 81.45% |
| 2014 Q3 | 8.03 Million CNY | 24.33% |
| 2014 Q1 | 6.46 Million CNY | 0.0% |
| 2014 FY | 28.99 Million CNY | 49.66% |
| 2014 Q2 | 6.46 Million CNY | -0.0% |
| 2014 Q4 | 8.03 Million CNY | 0.0% |
| 2013 FY | 19.37 Million CNY | 0.0% |